| Literature DB >> 28895082 |
Jin-Sun Jun1, Jangsup Moon1, Jung-Ick Byun2, Jun-Sang Sunwoo3, Jung-Ah Lim1, Soon-Tae Lee1, Keun-Hwa Jung1, Kyung-Il Park4, Ki-Young Jung1, Manho Kim1, Sang Kun Lee1, Kon Chu5.
Abstract
Parvovirus B19 (PVB19) has rarely been identified as a cause of encephalitis in immunocompetent adults, in whom clinical information regarding PVB19 encephalitis has remained unclear. Herein, we report the clinical presentations, laboratory and imaging findings, and treatment outcomes of five immunocompetent adults with PVB19 encephalitis. Although none of the patients showed any distinctive features of PVB19 infection, they showed various clinical manifestations, including one instance of brainstem involvement. Additionally, immunotherapy can be considered an effective approach, especially in immunocompetent adults with PVB19 encephalitis who are resistant to the initial management.Entities:
Keywords: Adult; B19; Encephalitis; Immunocompetent; Parvovirus
Mesh：
Substances：
Year: 2017 PMID： 28895082 DOI： 10.1007/s13365-017-0568-2
Source DB: PubMed Journal: J Neurovirol ISSN： 1355-0284 Impact factor: 3.739